Markets:

Overview

News

Currencies

International

Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.3200 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Vaxart’s Compelling Story Will Take a Long Time to Play Out ↗

June 03, 2021

As a company attempting to make oral vaccines, Vaxart has a compelling story. However VXRT stock looks to be many years away from paying off.

Via InvestorPlace

With Fading Covid-19 Infections, Vaxart’s Relevance Is Waning ↗

June 02, 2021

Prior to the vaccination rollout from Vaxart’s competitors, VXRT stock appeared a compelling alternative. That’s no longer the case.

Via InvestorPlace

Speculators Should Consider Buying Vaxart Stock ↗

May 26, 2021

Vaxart's vaccine pill could prove to be effective against the original Covid-19 virus and its new variants, sending VXRT stock sky-high.

Via InvestorPlace

Vaxart Could Still Be a Viable Covid 19 Vaccine Play ↗

May 18, 2021

VXRT stock needs to nail the next few studies of its Covid-19 vaccine candidate and prove its thesis to strengthen its bull case.

Via InvestorPlace

Ocugen or Vaxart: Which Will Take Investors Further? ↗

May 15, 2021

These two high-flying biotechs are vying for the same market.

Via The Motley Fool

High Cash Burn Will Push Vaxart Stock Down To $1 Per Share ↗

May 14, 2021

Failed clinical trials and high cash burn mean Vaxart is headed down to cash per share levels. That suggests VXRT stock is worth just $1.

Via InvestorPlace

It Won’t Take Much for Vaxart Stock to Pop Once Again ↗

May 14, 2021

Vaccine stocks are risky, but Americans nervous about a shot might make the difference for VXRT stock

Via InvestorPlace

Is Vaxart a Buy? ↗

May 12, 2021

Can this troubled coronavirus vaccine developer redeem itself and its investors?

Via The Motley Fool

Vaxart’s No-Shot Vaccine Is a Potential Game Changer ↗

May 11, 2021

VXRT stock is down from its highs, but there's no need to worry, as Vaxart has a unique Covid-19 vaccine and some encouraging clinical data.

Via InvestorPlace

Is Vaccine Maker Vaxart Worth Holding From Here? ↗

May 09, 2021

As with most investment decisions, whether to hold depends on the situation. Here are some things to think about.

Via The Motley Fool

Better Vaccine Stock: Ocugen or Vaxart? ↗

May 07, 2021

Here's how the biotechs compare on several key fronts.

Via The Motley Fool

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 06, 2021

Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares surged 92.9% to $2.3150. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 06, 2021

Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares...

Via Benzinga

30 Stocks Moving in Thursday's Pre-Market Session ↗

May 06, 2021

Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutics showcased data for Elamipretide in dry age-related...

Via Benzinga

Vaxart's Vaccine Candidate Is a Pill, Not a Shot. Does It Matter? ↗

May 06, 2021

If it can reach the market of people that are hesitant to be vaccinated, yes.

Via The Motley Fool

Vaxart Has 3 Advantages Over Pfizer and Moderna ↗

May 06, 2021

Its coronavirus vaccine candidate may stand out, if upcoming trials are successful.

Via The Motley Fool

70 Biggest Movers From Yesterday ↗

May 06, 2021

Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters...

Via Benzinga

64 Biggest Movers From Yesterday ↗

May 05, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...

Via Benzinga

Why Vaxart Stock Is Surging Today ↗

May 04, 2021

Investors are excited about the company's experimental COVID-19 vaccine.

Via The Motley Fool

44 Stocks Moving In Tuesday's Mid-Day Session ↗

May 04, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target...

Via Benzinga

Why Vaxart Shares Popped 78% in April ↗

May 04, 2021

Shareholders keep getting their hopes up for the company's tablet-based COVID-19 vaccine.

Via The Motley Fool

Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants ↗

May 04, 2021

Vaxart Inc has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1.

Via Talk Markets

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 04, 2021

Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7...

Via Benzinga

Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants ↗

May 04, 2021

Vaxart Inc (NASDAQ: VXRT) has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1. Data obtained...

Via Benzinga

26 Stocks Moving in Tuesday's Pre-Market Session ↗

May 04, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares rose 60.5% to $1.99 in pre-market trading. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...

Via Benzinga

52 Biggest Movers From Yesterday ↗

May 04, 2021

Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 03, 2021

Gainers Precipio (NASDAQ:

Via Benzinga

Vaxart Slides After Reporting Delay Of Trial For Potential COVID-19 Oral Vaccine ↗

May 03, 2021

Shares of Vaxart are under pressure on Monday after the company reported worse-than-expected first quarter losses and said that its Phase II trial of VXA-CoV2-1 is now expected to start mid-year 2021...

Via Talk Markets

Mid-Afternoon Market Update: Crude Oil Rises 1.5%; AVROBIO Shares Plummet ↗

May 03, 2021

Toward the end of trading Monday, the Dow traded up 0.82% to 34,152.49 while the NASDAQ fell 0.36% to 13,912.07. The S&P also rose, gaining 0.41% to 4,198.29. The U.S. has the...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.